TSXV:CLAS.H - Post by User
Comment by
SuperMoneyon May 05, 2019 11:09am
90 Views
Post# 29712183
RE:RE:RE:2nd cohort update
RE:RE:RE:2nd cohort updateJack and Bigbanktheory, thanks for your formation that are very useful. Could you please summarize your findings? Meanwhile, What is your speculation on the share price based on your findings? Thanks very much. Good luck to all shareholders!
Jack4000 wrote: wrote: Jack4000: i was referring to this message,
Right on. Thanks.
MonkVestor wrote: I think we're gonna get some results from the 2nd cohort (150 mg of CBD) pretty soon...so with a good outcome expected the wind will start blowin' in the right direction (last update march 22nd..)
Might start but don't look for a big change till we get PH III approval.
.
bigbanktheory wrote: it might be a bit of a logical step to compare how other medical mj companies have done in the past to possibly give us a bit of insight as to what might happen with the next round of results,
June 2018 GW Pharma gets approval for Epidiolex and sp goes from $139 to $160
They were in PH III as of May 2017
March 2016 looks like they were in PH 2b and the SP had just doubled to $141 from a positive 120 person trial.
So, without going into it deeper it looks like we would see a bumb but not a blowout.